HRT Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8M | Sell |
20,624
-2,875
| -12% | -$1.51M | 0.05% | 225 |
|
|
2025
Q1 | $14.9M | Buy |
23,499
+14,967
| +175% | +$9.49M | 0.09% | 132 |
|
|
2024
Q4 | $6.08M | Buy |
8,532
+4,696
| +122% | +$3.34M | 0.03% | 283 |
|
|
2024
Q3 | $4.03M | Buy |
+3,836
| New | +$4.03M | 0.02% | 524 |
|
|
2024
Q2 | – | Sell |
-11,058
| Closed | -$10.6M | – | 2766 |
|
|
2024
Q1 | $10.6M | Buy |
11,058
+4,992
| +82% | +$4.8M | 0.07% | 138 |
|
|
2023
Q4 | $5.33M | Sell |
6,066
-4,590
| -43% | -$4.03M | 0.04% | 268 |
|
|
2023
Q3 | $8.77M | Buy |
+10,656
| New | +$8.77M | 0.09% | 148 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2917 |
|
|
2023
Q1 | – | Sell |
-40,648
| Closed | -$29.3M | – | 2865 |
|
|
2022
Q4 | $29.3M | Buy |
+40,648
| New | +$29.3M | 0.41% | 32 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3199 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3403 |
|
|
2021
Q4 | – | Sell |
-17,847
| Closed | -$10.8M | – | 3598 |
|
|
2021
Q3 | $10.8M | Buy |
17,847
+3,896
| +28% | +$2.36M | 0.07% | 129 |
|
|
2021
Q2 | $7.79M | Sell |
13,951
-1,756
| -11% | -$981K | 0.07% | 210 |
|
|
2021
Q1 | $7.43M | Buy |
+15,707
| New | +$7.43M | 0.08% | 168 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2269 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2157 |
|
|
2020
Q1 | – | Sell |
-3,815
| Closed | -$1.43M | – | 1136 |
|
|
2019
Q4 | $1.43M | Buy |
3,815
+1,497
| +65% | +$562K | 0.06% | 217 |
|
|
2019
Q3 | $643K | Buy |
+2,318
| New | +$643K | 0.03% | 466 |
|
|
2018
Q4 | – | Sell |
-2,018
| Closed | -$815K | – | 686 |
|
|
2018
Q3 | $815K | Buy |
+2,018
| New | +$815K | 0.13% | 103 |
|
|
2018
Q2 | – | Sell |
-1,010
| Closed | -$347K | – | 338 |
|
|
2018
Q1 | $347K | Buy |
+1,010
| New | +$347K | 0.17% | 121 |
|
|
2015
Q4 | – | Sell |
-1,509
| Closed | -$701K | – | 110 |
|
|
2015
Q3 | $701K | Buy |
+1,509
| New | +$701K | 0.6% | 29 |
|